SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-020752
Filing Date
2019-11-18
Accepted
2019-11-18 09:36:32
Documents
3
Period of Report
2019-11-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K nc10006218x1_8k.htm 8-K 22374
2 EXHIBIT 1.1 nc10006218x1_ex1-1.htm EX-1.1 193950
3 EXHIBIT 5.1 nc10006218x1_ex5-1.htm EX-5.1 4859
  Complete submission text file 0001140361-19-020752.txt   222311
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 191226388
SIC: 2836 Biological Products, (No Diagnostic Substances)